Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report released on Sunday morning. The firm issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance NASDAQ ADXS opened at $0.03 on Friday. The stock has a market cap of $1.15 million, a PE ratio of 0.00 and a […]
More Stories
Evercore ISI Issues Positive Forecast for American Airlines Group (NASDAQ:AAL) Stock Price
American Airlines Group (NASDAQ:AAL – Get Free Report) had its target price upped by equities research analysts at Evercore ISI...
AerSale Corporation Evaluates Progress on Insurance Claim Following Fire Incident
AerSale Corporation, a leader in the aviation aftermarket solutions sector, recently provided an update on the aftermath of a fire...
Collegium Pharmaceutical Announces 2025 Financial Guidance and Corporate Presentation – What Investors Need to Know
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) recently disclosed its full-year revenue, adjusted operating expense, and adjusted EBITDA guidance for 2025 in...
Greenwave Technology Solutions, Inc. Cancels Special Meeting of Stockholders
Greenwave Technology Solutions, Inc. filed a Form 8-K with the Securities and Exchange Commission on January 8, 2025, announcing the...
Western Acquisition Ventures (NASDAQ: WAVSU) Enters into Promissory Notes for Transaction Expenses with Cycurion Inc.
Western Acquisition Ventures Corp. filed a Form 8-K with the Securities and Exchange Commission on January 6, 2025, indicating the...
Walker River Resources (CVE:WRR) Trading Up 11.4% – Should You Buy?
Walker River Resources Corp. (CVE:WRR – Get Free Report) was up 11.4% during trading on Thursday . The company traded...